Chong Chen is listed as an executive officer and director on 2 SEC Form D filings by 1 issuer between Jan 2020 and Mar 2020: Synergenetics Bioscience Inc. (Vancouver, British Columbia, Canada (as filed: A1) — biotechnology — 2020; $300K reported sold to 2 investors).
What this means One deal on file with the SEC, filed Mar 2020. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Ling Zhang (2 shared filings) and Ping Zhang (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Chong. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Chong Chen and found 2 differences: Chong Chen's role changed at Synergenetics Bioscience Inc.: executive officer, director → executive officer; Same name, different state: "Chong Tong Bill Chen" (NY) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.